Reset filters
  • 13 September 2013

New tenofovir formulation works equally well with less effect on kidneys and bones

Read the article
Dr Paul Sax of Brigham & Women's Hospital, Boston. Photo by Liz Highleyman, hivandhepatitis.com
  • 13 September 2013

Raltegravir is a good choice for people with HIV undergoing cancer chemotherapy

Read the article
  • 13 September 2013

CD4 gene therapy may enable functional HIV control during treatment interruption

Read the article
L to R: Moderators Joseph Eron and Pablo Tebas, presenter Dale Ando from Sangamo (photo by Liz Highleyman, hivandhepatitis.com).
  • 12 September 2013

Systematic review confirms that regular viral load monitoring assists adherence to HIV therapy

Read the article
  • 10 September 2013

Loss of kidney function in older people with HIV underlines need for earlier treatment

Read the article
  • 8 September 2013

Starting HIV therapy leads to improvements in daily function and economic wellbeing

Read the article
  • 4 September 2013

Tenofovir is highly effective for HIV/HBV co-infection, meta-analysis shows

Read the article
  • 2 September 2013

People with HIV/HCV-co-infection and advanced liver fibrosis can rapidly develop decompensated liver disease

Read the article
  • 29 August 2013

Persisently detectable viral load at any level increases risk of HIV treatment failure

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.